Tag: medical-devices
Novanta Stock Analysis: Buy or Sell? Valuation, FCF & Margins
Novanta (NOVT) is rated Hold as its net cash balance sheet and 8.7% free cash flow margin are offset by a 5.2x EV/revenue multiple and 36.1x forward P/E. Q1 2026 revenue rose 10.4%, but earnings still declined, leaving the stock priced for cleaner execution than the latest results support.
Boston Scientific Stock Analysis: Valuation, Reimbursement Risk, Cash Flow & Growth
Boston Scientific (BSX) earns a Buy rating on double-digit revenue growth, expanding EBITDA, and improving free cash flow. The key question is whether management can sustain execution while navigating reimbursement pressure and acquisition-led capital deployment.
Intuitive Surgical Stock Analysis: Valuation, Procedure Growth, China Risk & Cash Flow
Intuitive Surgical (ISRG) earns a HOLD rating as its dominant installed base and recurring revenue continue to support strong cash generation. However, the stock already prices in durable execution at a rich valuation, with China tender delays and pricing pressure clouding near-term upside.
Abbott Laboratories Stock Analysis: Valuation, Margins, Debt & Growth
Abbott Laboratories (ABT) is rated Hold as its diversified healthcare platform supports stability, but valuation and execution concerns cap near-term upside. Q1 2026 revenue and EBIT weakened sequentially, while debt tied to acquisition financing could pressure flexibility.